BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32743527)

  • 1. Immunometabolism in the pathogenesis of systemic lupus erythematosus.
    Zhang CX; Wang HY; Yin L; Mao YY; Zhou W
    J Transl Autoimmun; 2020; 3():100046. PubMed ID: 32743527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunometabolism and systemic lupus erythematosus].
    Xiao YB; Guo MY; Zuo XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunometabolism in the pathogenesis of systemic lupus erythematosus: an update.
    Romo-Tena J; Kaplan MJ
    Curr Opin Rheumatol; 2020 Nov; 32(6):562-571. PubMed ID: 32826478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications.
    Tzeng HT; Chyuan IT
    J Formos Med Assoc; 2021 Sep; 120(9):1667-1675. PubMed ID: 33836940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunometabolism in systemic lupus erythematosus.
    Morel L
    Nat Rev Rheumatol; 2017 May; 13(5):280-290. PubMed ID: 28360423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cellular overview of immunometabolism in systemic lupus erythematosus.
    Psarras A; Clarke A
    Oxf Open Immunol; 2023; 4(1):iqad005. PubMed ID: 37554724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell metabolism and possible therapeutic targets in systemic lupus erythematosus: a narrative review.
    Muñoz-Urbano M; Quintero-González DC; Vasquez G
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):457-470. PubMed ID: 35352607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus.
    Wincup C; Radziszewska A
    Rheum Dis Clin North Am; 2021 Aug; 47(3):427-439. PubMed ID: 34215372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking "Inflammaging" in Patients with Systemic Lupus Erythematosus.
    Tsai CY; Shen CY; Liao HT; Li KJ; Lee HT; Lu CS; Wu CH; Kuo YM; Hsieh SC; Yu CL
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus.
    Takeshima Y; Iwasaki Y; Fujio K; Yamamoto K
    Semin Arthritis Rheum; 2019 Jun; 48(6):1142-1145. PubMed ID: 31056210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Immunometabolism in the Pathogenesis of Systemic Lupus Erythematosus.
    Robinson GA; Wilkinson MGL; Wincup C
    Front Immunol; 2021; 12():806560. PubMed ID: 35154082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting abnormal lipid metabolism of T cells for systemic lupus erythematosus treatment.
    Hu JQ; Yan YH; Xie H; Feng XB; Ge WH; Zhou H; Yu LL; Sun LY; Xie Y
    Biomed Pharmacother; 2023 Sep; 165():115198. PubMed ID: 37536033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immmunometabolism of systemic lupus erythematosus.
    Furment MM; Perl A
    Clin Immunol; 2024 Apr; 261():109939. PubMed ID: 38382658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus.
    Wincup C; Sawford N; Rahman A
    Expert Rev Clin Immunol; 2021 Sep; 17(9):957-967. PubMed ID: 34263712
    [No Abstract]   [Full Text] [Related]  

  • 15. Promising roles of combined therapy based on immune response and iron metabolism in systemic lupus erythematosus.
    Xing Z; Gao S; Zheng A; Tong C; Fang Y; Xiang Z; Chen S; Wang W; Hua C
    Int Immunopharmacol; 2024 Jun; 138():112481. PubMed ID: 38917527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Iwata S; Tanaka Y
    Expert Rev Clin Immunol; 2021 Oct; 17(10):1121-1130. PubMed ID: 34351835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions.
    Saadh MJ; Kazemi K; Khorramdelazad H; Mousavi MJ; Noroozi N; Masoumi M; Karami J
    Int Immunopharmacol; 2023 Jun; 119():110246. PubMed ID: 37148769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic determinants of lupus pathogenesis.
    Teng X; Brown J; Choi SC; Li W; Morel L
    Immunol Rev; 2020 May; 295(1):167-186. PubMed ID: 32162304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus.
    Zhao L; Hu X; Xiao F; Zhang X; Zhao L; Wang M
    Front Immunol; 2022; 13():929520. PubMed ID: 35958572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications.
    Yennemadi AS; Keane J; Leisching G
    Lupus; 2023 Apr; 32(5):603-611. PubMed ID: 36914582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.